United Kingdom

People: Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

5:42pm BST
Change (% chg)

$0.37 (+1.41%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lackner, Thomas 

Mr. Thomas Lackner is Senior Vice President, Head of Europe of the Company. He has served as our Senior Vice President, Head of Europe, since January 2019. From January 2017 to December 2018 he served as Vice President, Head of European Commercial Operations at Prothena Corporation plc., a public biotechnology company. From January 2002 to December 2016 he served in various leadership roles at Biogen Corporation, a public technology company, including as Vice President and Managing Director for Germany, Austria and Switzerland from October 2010 to December 2016. Mr. Lackner holds an M.B.A. from Texas A&M University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --